Okhovat, Mariam http://orcid.org/0000-0002-3145-9397
VanCampen, Jake
Nevonen, Kimberly A.
Harshman, Lana
Li, Weiyu
Layman, Cora E.
Ward, Samantha
Herrera, Jarod
Wells, Jackson
Sheng, Rory R. http://orcid.org/0000-0002-9254-8836
Mao, Yafei http://orcid.org/0000-0002-9648-4278
Ndjamen, Blaise
Lima, Ana C. http://orcid.org/0000-0002-5726-4168
Vigh-Conrad, Katinka A.
Stendahl, Alexandra M. http://orcid.org/0000-0002-2977-4806
Yang, Ran http://orcid.org/0000-0001-6104-2691
Fedorov, Lev
Matthews, Ian R.
Easow, Sarah A. http://orcid.org/0000-0002-0849-8363
Chan, Dylan K.
Jan, Taha A. http://orcid.org/0000-0001-8971-7769
Eichler, Evan E.
Rugonyi, Sandra http://orcid.org/0000-0001-9262-7959
Conrad, Donald F. http://orcid.org/0000-0003-3828-8970
Ahituv, Nadav http://orcid.org/0000-0002-7434-8144
Carbone, Lucia http://orcid.org/0000-0002-2118-107X
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute (R01HG010333, R01HG002385, R01HG010333)
U.S. Department of Health & Human Services | NIH | NIH Office of the Director (P51 OD011092, P51 OD011092)
U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute
Howard Hughes Medical Institute
U.S. Department of Health & Human Services | NIH | NIH Office of the Director
U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute
Article History
Received: 30 March 2023
Accepted: 21 November 2023
First Online: 7 December 2023
Competing interests
: E.E.E. is a scientific advisory board (SAB) member of Variant Bio, Inc. N.A. is the cofounder and on the scientific advisory board of Regel Therapeutics and receives funding from BioMarin Pharmaceutical Incorporated. The remaining authors declare no competing interests.